Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies

Journal of Molecular Medicine

Volumn 77, Issue 1, 1999, Pages 226-229

  Kuttler, B ^a   Rosing K ^a   Lehmann, M ^b   Brock, J ^b   Hahn, H J ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b NONE

Author keywords

BB rat; Disease recurrence; Immunotherapy; Islet transplantation; Rejection

Indexed keywords

CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; OKT 4;

ALLOIMMUNITY; ANIMAL MODEL; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; RAT; RECURRENT DISEASE;

EID: 0033047990     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050342     Document Type: Conference Paper

References (19)

1. 1. Alters SE, Grossman D, Fathman CG (1992) Anti-CD4-mediated transplantation tolerance: mechanisms and memory. In: Burlingham WJ (ed) A Critical Analysis of Monoclonal Antibody Therapy in Transplantation. CRC Press Boca Raton, Ann Arbor, London, pp 79-99
2. 2. Waldmann TA (1993) The IL-2/IL-2 receptor system: a target for rational immune intervention. Immunol Today 14: 264-270
3. 3. Diamantstein T, Hahn HJ (1993) Interleukin-2 receptor-targeted immune therapy. In: Bach J-F (ed) Monoclonal Antibodies and Peptide Therapy in Autoimmune Diseases. Marcel Dekker, New York, Basel, Hong Kong, pp 295-318
4. 4. Soulillou JP, Cantarovich D, Dantal J, Hourmont M, Le Mauff B, Yannik J (1992) Anti-IL-2 receptor and anti-LFA-1 monoclonal antibodies in transplantation: rationale and Nantes clinical experience. In: Burlingham WJ (ed) A Critical Analysis of Monoclonal Antibody Therapy in Transplantation. CRC Press Boca Raton, Ann Arbor, London, pp 47-66
5. 5. Wood MJ, Sloan DJ, Dallmann MJ, Charlton HM (1993) Specific tolerance to neural allografts induced with an antibody to the interleukin 2 receptor. J Exp Med 177: 597-603
6. 6. Hahn HJ, Kuttler B, Klöting I, Dunger A, Besch W, Diamantstein T (1992) Extended survival of MHC-identical allogeneic islet grafts in diabetic BB rats - the effect of an interleukin 2 receptor-targeted immunotherapy. Transplantation 54: 555-558
7. 7. Kuttler B, Lucke S, Vogt L, Klöting I, Diamantstein T, Hahn HJ (1996) Immunotherapy of insulin-dependent diabetes mellitus: Tolerance after short-term anti-IL2 receptor/ cyclosporine therapy in BB/OK rats. In: Shafrir E (ed) Lessons from Animal Diabetes Volume 6. Smith-Gordon & Co, London, pp 57-76
8. + T-cell-mediated tolerance in BB/OK rats. J Autoimmunity 9: 321-329
9. 9. Lehmann M, Sternkopf F, Metz F, Brock J, Döcke WD, Plantikow A, Kuttler B, Hahn HJ, Ringel B, Volk HD (1992) Induction of long-term survival of rat skin allografts by a novel, highly efficient anti-CD4 monoclonal antibody. Transplantation 54: 959-962
10. 10. Lehmann M, Kuttler B, Siegling A, Gordalla A, Riedel H, Jacha J, Hahn HJ Brock J, Volk HD (1993) Characterization of the anti-CD4-induced permanent acceptance of rat renal allografts. Transplant Proc 25: 2859-2860
11. 11. Kuttler B, Lehmann M, Lacha J, Brock J, Hahn HJ (1994) Anti-CD4 therapy induces a donor-specific, organ-unspecific tolerance in allogeneic kidney graft recipients. Transplant Proc 26: 728-729
12. 12. Klöting I, Reiher K (1985) Some genetic aspects to the management and reproduction of diabetes-prone BB rats. Z Versuchstierk 27: 5-11
13. 13. Klöting I, Vogt L, Günther E, Wurst W, Hedrich HJ, Reetz IC (1989) Availability of new established congenic rat strains LEW.1BB and BB.1A. Rat News Lett 21: 22-23
14. 14. Hehmke B, Kohnert KD, Odselius P (1986) The use of a new dextran gradient for rapid isolation of functionally intact neonatal pancreatic islets. Diabetes Res 3: 13-16
15. 15. Lucke S, Liepe L, Todoran L, Besch W, Diamantstein T, Hahn HJ (1990) Phenotyping of cells infiltrating the pancreas of diabetic BB rats depending on duration of diabetes. In: Shafrir E (ed) Lessons from Animal Diabetes Vol. 3. Smith-Gordon & Co, London, pp 34-37
16. 16. Hahn HJ, Kuttler B, Lucke S, Dunger A, Besch W, Volk HD, Diamantstein T (1989) Effect of temporary IL-2 receptor mab therapy on islet allograft survival in autoimmune diabetes. Transplant Proc 21: 2711-2713
17. 17. Posselt AM, Naji A, Roark JH, Markmann JF, Barker CF (1991) Intrathymic islet transplantation in the spontaneously diabetic BB rat. Ann Surg 214: 363-371
18. 18. Purcell LJ, Mottram PL (1995) Prevention of both rejection and recurrence of autoimmune disease in the NOD/Lt mouse following segmental pancreas transplantation. Transplant Proc 27: 2166-2167
19. 19. Hahn HJ, Kuttler B, Kauert C, Dunger A, Diamantstein T (1989) Interleukin-2 receptor targeted immunotherapy in the prevention of autoimmune beta-cell destruction as observed in diabetic BB/OK Rats grafted with BB/OK rat islets. Autoimmunity 5: 139-142